Building Medical Affairs Teams of The Future: A Strategic Advantage in the Age of Data Driven Health
October 14, 2020 8:00 AM - 9:00 AM
Webinar, click "live-stream" button to view
Medical Affairs was created as a support function to marketing and sales but has evolved over the last decade into the third pillar of pharmaceutical and biotechnology companies. Today, with the breadth and depth of diverse data sources, rapid changes in technology, increasing scientific complexity of treatments, and regulatory and economic trends, organizations that cultivate strategic and diversely talented medical teams have the competitive advantage.
Forward looking organizations are building the medical affairs teams of the future. These teams are breaking down traditional silos and developing capacities to evolve data generation across clinical development, HEOR and real-world evidence. They are evolving to effectively translate, not only the clinical, but also the economic impact to increasingly important stakeholders, especially payer decision-makers with unprecedented size and scale and knowledge-empowered patients.
In a day of rapid scientific and medical advancement, equity, and economic concerns, the pharmaceutical industry requires strategic medical leadership. Required are highly skilled and empowered medical affairs teams that harness data and insights to help physicians, payers, and patients choose the right medication, at the right time, to drive meaningful impact for individual patients and societal health outcomes.
Join us for an overview from McKinsey of how medical affairs has evolved over time and where it is headed followed by a panel discussion on how life sciences companies of all sizes can best hire, develop, and leverage these skilled professionals for a competitive advantage.
Sponsored by the MassBio MarCom and Commercial Forum Working Group.
MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
- John B. Pracyk, MD, PhD, MBA
- Leader, Preclinical & Clinical Research and Medical Affairs, DePuy Synthes Spine
- John Pracyk, MD, PhD, MBA, is an Integrated Leader - Preclinical & Clinical Research and Medical Affairs at DePuy Synthes Spine, (Johnson & Johnson Medical Devices Companies), and President of the Americas, and member of the Board of Directors, The Medical Affairs Professional Society. John is an executive medical affairs leader focusing on the design, development, and commercialization of medical devices. As a Neurological Surgeon/ Neuroscientist with an uncommon blend of business and medical expertise he is a passionate proponent of value-based care and outcomes-driven, evidence-based practices. He is a recognized thought leader and program architect in the creation and management of collaborative healthcare delivery platforms with a proven track record of multidisciplinary program build-outs and care redesign successes. John obtained his BS, MD, and PhD degrees through the Early Identification & Medical Scientist Training Programs at Duke University and was competitively awarded postdoctoral fellowships at The University of Cambridge and The National Institutes of Health. John also obtained a MBA at the Haslam College of Business, at the University of Tennessee, and is a Diplomate of the American Board of Neurological Surgeons, a Fellow of the American Association of Neurological Surgeons (FAANS) and a Fellow of the American College of Surgeons (FACS).
- See All Sessions
- Laura Saltonstall
- MD, Vice President, U.S. and LATAM Medical Affairs, Alnylam Pharmaceuticals
- Laura is Vice President, U.S. & LATAM Medical Affairs at Alnylam, where she is responsible for leading the U.S. and LATAM Medical Affairs organization across all therapeutic areas. During her tenure at Alnylam, she has supported the launches of ONPATTRO, GIVLAARI and lumasiran. Prior to joining Alnylam, Laura spent 14 years at Sanofi Genzyme where she was most recently Vice President, Head of Multiple Sclerosis Medical Affairs in North America. Earlier at Sanofi, she led the US LEMTRADA Medical Directors team and established the Multiple Sclerosis global scientific communications group. In these roles, she helped launch two therapies for multiple sclerosis, AUBAGIO and LEMTRADA. Prior to her tenure in medical affairs, Laura worked in oncology business development, program management, strategy as well as marketing in roles of increasing responsibility. Laura holds an AB from Harvard College, an MD from Harvard Medical School and an MBA from MIT’s Sloan School of Management. She trained for two years as an OB-GYN at the Brigham and Women’s Hospital and Massachusetts General Hospital. When not working, Laura enjoys spending time with family and friends, reading, skiing, traveling and playing tennis. Laura serves on the board of trustees for Vincent Memorial Hospital, The Boston Home and the Massachusetts Eye and Ear Infirmary. She lives in Newton with her husband and three daughters.
- See All Sessions
- Marie E. Sanchirico, PhD
- Director, Health Economics and Outcomes Research, US, Takeda
- Marie is a biopharma professional and PhD immunologist with over 15 years of biopharmaceutical experience in complex specialty drug care. Marie currently works as Director of Outcomes Research at Takeda Pharmaceuticals. Prior to Takeda, Marie worked in national medical access roles at Sanofi Genzyme and Intercept Pharmaceuticals, helping create access with both national US payers and PBMs for 7 drug launches. Before joining the pharmaceutical industry, Marie was an associate professor at UMASS Medical School and Instructor of Medicine at Harvard Medical School. Marie received her bachelor’s degree in biochemistry at Ithaca College, her PhD from UMASS, Amherst and specialty trained in immunology as an NIH postdoctoral fellow and Instructor of medicine at Harvard Medical school/Dana Farber Cancer Institute. Marie has three teenage daughters (ages 19, 17 and 13), is a dedicated hot yogi and outdoor enthusiast and was once pulled over for speeding on a jet ski.
- See All Sessions
- Ann Westra, MD
- Senior Knowledge Expert, McKinsey & Company
- Ann is a Senior Knowledge Expert in McKinsey’s Minneapolis Office. In her 10+ years at the Firm, she has served clients across the pharmaceutical industry, focused on medical topics including Chief Medical Officers, Medical Affairs, and real-world evidence. Ann leads McKinsey’s medical service line and related internal knowledge efforts in Medical Affairs, Real World Evidence and other related topics. She serves top pharmaceutical companies on medical topics, including redesigning medical customer engagement globally, aligning global-local medical strategy and organizing global Medical Affairs organizations. Ann co-leads multiple cross-industry forums on medical topics with participants from most of the top 25 pharma companies, including our Pharma CMO Roundtable and Medical Affairs Leader Forum. She co-developed talent building programs for high-potential leaders and Medical Affairs and Regulatory Affairs that build skills in business leadership, strategic vision and communication skills/emotional intelligence. Prior to joining McKinsey & Company, Ann earned her M.D. from Johns Hopkins University School of Medicine and completed her residency in pediatrics at New York Hospital / Weill Cornell Medicine.
- See All Sessions